Where do Palvella Therapeutics's ratios come from?

Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on assets	-28.7%+27.7pp	-56.5%+18.9pp	-75.4%-17.9pp	-57.5%-15.1pp	-42.4%-6.0pp
Liquidity
Current ratio	28.9×+23.7×	5.2×-1.3×	6.5×—	——	——
Quick ratio	28.9×+23.7×	5.2×-1.3×	6.5×—	——	——
Cash ratio	22.6×+17.5×	5.1×-1.1×	6.2×-1.2×	7.3×-1.1×	8.4×+1.5×
Per Share
Book value per share	$17.75+614%	$2.49-28.9%	$3.50-19.1%	$4.32-14.3%	$5.05-82.1%
Valuation
Market capitalization	$1.78B+44.0%	$1.24B+78.7%	$693.33M—	——	——
Price / book	7.7×-36.6×	44.3×+26.4×	17.9×—	——	——
Earnings yield	-2.8%+0.6pp	-3.4%+1.4pp	-4.8%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Palvella Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Palvella Therapeutics's ratios come from?: Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.